Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study Between Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in the Treatment of ARDS Induced by Both Lung Trauma and VAP

NCT04402359 is registered in ClinicalTrials.gov with King Abdul Aziz Specialist Hospital as lead sponsor.

NCT NCT04402359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04402359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study Between Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in the Treatment of ARDS Induced by Both Lung Trauma and VAP
Lead sponsor
King Abdul Aziz Specialist Hospital
Phase
Observational
Overall status
Completed
Start date
July 5, 2018
Completion date
December 30, 2019
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator associated pneumonia